— Know what they know.
Not Investment Advice

IGC Earnings

IGC Pharma, Inc.
1W: -2.7% 1M: -7.1% 3M: -2.2% YTD: -5.5% 1Y: -33.2% 3Y: -23.1% 5Y: -82.0%
$0.27
+0.00 (+1.81%)
 
Weekly Expected Move ±5.9%
$0 $0 $0 $0 $0
AMEX · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $27.5M mcap · 86M float · 0.751% daily turnover · Short 28% of daily vol
Last Earnings 2026-08-14
EPS
$-0.03
▼ Miss -50.0%
Revenue
$265K
▲ Beat +61.6%
Next Earnings 2026-11-13
EPS Estimate
$-0.02
Range: $-0.02 - $-0.02
Revenue Estimate
$280K
1 analysts

Estimate vs Actual

Earnings Surprise History

5/19
EPS Beats
8/19
Revenue Beats
26%
EPS Beat Rate
42%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-08-31 quarter 2027-06-30 $-0.02 $-0.02 — $164,000 $265,000
2026-08-17 quarter 2026-12-30 $-0.03 $-0.02 — $251,000 $280,000
2026-08-17 quarter 2027-12-30 $— $-0.02 ▼ 0.02 $— $280,000
2026-08-17 quarter 2027-03-30 $-0.03 $-0.02 — $257,000 $317,000
2026-07-29 annual 2023-03-31 $— $0.42 ▲ 0.42 $— $22,200,000
2026-07-29 quarter 2010-09-30 $— $1.68 ▲ 1.68 $— $7,517,400
2026-07-29 quarter 2023-12-31 $— $-0.04 ▼ 0.04 $— $400,000
2026-07-29 quarter 2010-06-30 $— $0.52 ▲ 0.52 $— $355,142
2026-07-29 quarter 2024-03-31 $-0.04 $-0.04 — $193,000 $400,000
2026-07-29 annual 2015-03-31 $— $0.09 ▲ 0.09 $— $11,400,000
2026-07-29 annual 2016-03-31 $— $0.42 ▲ 0.42 $— $22,200,000
2026-07-29 annual 2022-03-31 $— $0.09 ▲ 0.09 $— $11,400,000
2026-07-29 quarter 2010-12-31 $— $-3.13 ▼ 3.13 $— $478,905
2026-07-29 annual 2024-03-31 $-0.21 $-0.22 ▼ 0.01 $1,062,000 $1,243,000
2026-07-27 quarter 2024-09-30 $-0.03 $-0.04 ▼ 0.01 $450,000 $400,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms